User:Karmella Haynes/Notebook/Polycomb project/2010/07/03

{| width="800"
 * style="background-color: #EEE"|[[Image:owwnotebook_icon.png|128px]] Project name
 * style="background-color: #F2F2F2" align="center"|  |Main project page
 * style="background-color: #F2F2F2" align="center"|  |Main project page


 * colspan="2"|
 * colspan="2"|

07/03/10

 * &#x2713; Senescence assay (optimization): flow cytometry for C12-FDG titration
 * &#x2713; Senescence assay: set up 6-well plates for 126-1, 126-3, 132-8, 154-2 -/+ dox; FTRx DMSO/rotenone
 * &#x2713; Transformation prep: FTRx 6-well (new stable lines for KAH130, 131)
 * &#x2713; Cell culture: split confluent stock cultures
 * &#x2713; RT-PCR cultures: set up 6-well plates (-/+ dox samples) to re-do RT-PCR (next time use less RNA for cDNA synth); 126-1, 126-3, 132-8, 154-2, FTRx
 * &#x2713; p16INK western/RT-PCR: FTRx 6-well -/+ 0.2 μg/mL rotenone; FTRx 10 cm plate -/+ μg/mL rotenone

Senescence assay optimization > Flow cytometry cell samples 1-6. Plate 1: Untreated (DMSO) 7-12. Plate 2: 0.2 μg/mL rotenone (3 days) blank: FRTX cells (stock culture), no C12-FDG

> C12-FDG treatment (37°C/ 45 min.) --> use 1/10 serial dilution 1,7. 0 C12-FDG/ 30 μL DMSO 2,8. 0.0015 μg/mL C12-FDG/ 30 μL DMSO 3,9. 0.015 μg/mL C12-FDG/ 30 μL DMSO 4,10. 0.15 μg/mL C12-FDG/ 30 μL DMSO 5,11. 1.5 μg/mL C12-FDG/ 30 μL DMSO 6,12. 15.0 μg/mL C12-FDG/ 30 μL DMSO

> Results: Could see slight but subjectively significant increase in FITC signal for rotenone treated cells for 0.15, 1.5, and 15.0 μg/mL C12-FDG samples. Background signal increases orders of magnitude with C12-FDG concentration. > Next: Set up dox induction of Pc-ATF lines and FTRx rotenone treatment (4 days) for next C12-FDG assay. Will determine whether RFP signal is associated with senescence (high FITC)


 * }